Evidence map›Paper›PMID 21673516›Full record

ArticleAutophagy2011

PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway.

Ying Huang, Jia-Kai Hou, Ting-Ting Chen, Xu-Yun Zhao, Zhao-Wen Yan, Jing Zhang, Jie Yang, Scott C Kogan, Guo-Qiang Chen

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (AML)?International journal of hematology-oncology and stem cell research · 2022
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Outer dense fibers stabilize the axoneme to maintain sperm motility.Journal of cellular and molecular medicine · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The tumor suppressor p53 fine-tunes reactive oxygen species levels and neurogenesis via PI3 kinase signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Ying HuangKey Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jia-Kai Hou
Ting-Ting Chen
Xu-Yun Zhao
Zhao-Wen Yan
Jing Zhang
Jie Yang
Scott C Kogan
Guo-Qiang Chen
Shanghai Jiao Tong University · CNInstitute for Biological Sciences · CAUniversity of California, San Francisco · US

Funding

Molecular Mechanisms of Leukemogenesis by PMLRAR alphaR01CA095274 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KOGAN, SCOTT C. · 2002 to 2013
$2.7M
NCI NIH HHS R01 CA095274
6 · The paper itself

Abstract

Autophagy is a highly conserved, closely regulated homeostatic cellular activity that allows for the bulk degradation of long-lived proteins and cytoplasmic organelles. Its roles in cancer initiation and progression and in determining the response of tumor cells to anticancer therapy are complicated, and only limited investigation has been conducted on the potential significance of autophagy in the pathogenesis and therapeutic response of acute myeloid leukemia. Here we demonstrate that the inducible or transfected expression of the acute promyelocytic leukemia (APL)-specific PML-RARα, but not PLZF-RARα or NPM-RARα, fusion protein upregulates constitutive autophagy activation in leukemic and nonleukemic cells, as evaluated by hallmarks for autophagy including transmission electron microscopy. The significant increase in autophagic activity is also found in the leukemic cells-infiltrated bone marrow and spleen from PML-RARα-transplanted leukemic mice. The autophagy inhibitor 3-methyladenine significantly abrogates the autophagic events upregulated by PML-RARα, while the autophagic flux assay reveals that the fusion protein induces autophagy by increasing the on-rate of autophagic sequestration. Furthermore, this modulation of autophagy by PML-RARα is possibly mediated by a decreased activation of the Akt/mTOR pathway. Finally, we also show that autophagy contributes to the anti-apoptotic function of the PML-RARα protein. Given the critical role of the PML-RARα oncoprotein in APL pathogenesis, this study suggests an important role of autophagy in the development and treatment of this disease.

Indexed as

ApoptosisAutophagyGene Expression Regulation, NeoplasticAdenineAnimalsHumansLeukemia, Promyelocytic, AcuteMiceMicrotubule-Associated ProteinsNeoplasm TransplantationOncogene Proteins, FusionProto-Oncogene Proteins c-aktRecombinant Fusion ProteinsTime FactorsTOR Serine-Threonine KinasesU937 Cells3-methyladenineAdenineMAP1LC3A protein, humanMicrotubule-Associated ProteinsMTOR protein, humanmTOR protein, mouseOncogene Proteins, Fusionpromyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinProto-Oncogene Proteins c-aktRecombinant Fusion ProteinsTOR Serine-Threonine Kinases

Identifiers

PMID21673516
PMCPMC3210306
OpenAlexW2110038243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.